| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ludwig Institute for Cancer Research, Brussels, Belgium; and Experimental Medicine Unit, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, Brussels, Belgium
IL-9 is a Th2 cytokine active on various cell types such as T and B lymphocytes, mast cells, and eosinophils, and potentially involved in allergy and asthma. To understand better the molecular mechanisms underlying the activity of this cytokine, we used a cDNA subtraction method to identify genes specifically induced by IL-9 in mouse T cells. One of the IL-9-regulated genes isolated by this approach turned out to encode a 180-amino acid long protein, including a potential signal peptide, and showing 22% amino acid identity with IL-10. This protein, designated IL-10-related T cell-derived inducible factor (IL-TIF), is induced by IL-9 in thymic lymphomas, T cells, and mast cells, and by lectins in freshly isolated splenocytes. Experiments concerning the mechanism regulating IL-TIF expression in T cells indicate that IL-9 induction is rapid (within 1 h), does not require protein synthesis, and depends on the activation of the Janus kinase (JAK)-STAT pathway. In vivo, constitutive expression of IL-TIF was detected by RT-PCR in thymus and brain, suggesting that the role of this new factor is not restricted to the immune system. Transfection of HEK293 cells with the IL-TIF cDNA resulted in the production of a glycosylated protein of about 25 kDa that was found to induce STAT activation in mesangial and neuronal cell lines. Further studies will have to address the possibility that some of the IL-9 activities may be mediated by IL-TIF.
This article has been cited by other articles:
|
|
 |
|
  S. M. Schulz, G. Kohler, N. Schutze, J. Knauer, R. K. Straubinger, A. A. Chackerian, E. Witte, K. Wolk, R. Sabat, Y. Iwakura, et al. Protective Immunity to Systemic Infection with Attenuated Salmonella enterica serovar Enteritidis in the Absence of IL-12 Is Associated with IL-23-Dependent IL-22, but Not IL-17 J. Immunol., December 1, 2008; 181(11): 7891 - 7901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, Y. Chen, H. Wei, C. Zheng, R. Sun, J. Zhang, and Z. Tian Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts Clin. Cancer Res., October 15, 2008; 14(20): 6432 - 6439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kreymborg, R. Etzensperger, L. Dumoutier, S. Haak, A. Rebollo, T. Buch, F. L. Heppner, J.-C. Renauld, and B. Becher IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis J. Immunol., December 15, 2007; 179(12): 8098 - 8104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Levillayer, M. Mas, F. Levi-Acobas, M. Brahic, and J. F. Bureau Interleukin 22 Is a Candidate Gene for Tmevp3, a Locus Controlling Theiler's Virus-Induced Neurological Diseases Genetics, July 1, 2007; 176(3): 1835 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wolk, E. Witte, U. Hoffmann, W.-D. Doecke, S. Endesfelder, K. Asadullah, W. Sterry, H.-D. Volk, B. M. Wittig, and R. Sabat IL-22 Induces Lipopolysaccharide-Binding Protein in Hepatocytes: A Potential Systemic Role of IL-22 in Crohn's Disease J. Immunol., May 1, 2007; 178(9): 5973 - 5981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Weber, S. Schlautkotter, S. Kaiser-Moore, F. Altmayr, B. Holzmann, and H. Weighardt Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis Infect. Immun., April 1, 2007; 75(4): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brand, J. Dambacher, F. Beigel, K. Zitzmann, M. H. J. Heeg, T. S. Weiss, T. Prufer, T. Olszak, C. J. Steib, M. Storr, et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1019 - G1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Weber, F. C. Gaertner, W. Erl, K.-P. Janssen, B. Blechert, B. Holzmann, H. Weighardt, and M. Essler IL-22-Mediated Tumor Growth Reduction Correlates with Inhibition of ERK1/2 and AKT Phosphorylation and Induction of Cell Cycle Arrest in the G2-M Phase J. Immunol., December 1, 2006; 177(11): 8266 - 8272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chang, H. Hanawa, H. Liu, T. Yoshida, M. Hayashi, R. Watanabe, S. Abe, K. Toba, K. Yoshida, R. Elnaggar, et al. Hydrodynamic-Based Delivery of an Interleukin-22-Ig Fusion Gene Ameliorates Experimental Autoimmune Myocarditis in Rats J. Immunol., September 15, 2006; 177(6): 3635 - 3643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brand, F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J.-M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G827 - G838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Galibert, G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. Nectin-like Protein 2 Defines a Subset of T-cell Zone Dendritic Cells and Is a Ligand for Class-I-restricted T-cell-associated Molecule J. Biol. Chem., June 10, 2005; 280(23): 21955 - 21964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Boniface, F.-X. Bernard, M. Garcia, A. L. Gurney, J.-C. Lecron, and F. Morel IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes J. Immunol., March 15, 2005; 174(6): 3695 - 3702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hor, H. Pirzer, L. Dumoutier, F. Bauer, S. Wittmann, H. Sticht, J.-C. Renauld, R. de Waal Malefyt, and H. Fickenscher The T-cell Lymphokine Interleukin-26 Targets Epithelial Cells through the Interleukin-20 Receptor 1 and Interleukin-10 Receptor 2 Chains J. Biol. Chem., August 6, 2004; 279(32): 33343 - 33351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Donnelly, F. Sheikh, S. V. Kotenko, and H. Dickensheets The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain J. Leukoc. Biol., August 1, 2004; 76(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Whittington, L. Armstrong, K. M. Uppington, and A. B. Millar Interleukin-22: A Potential Immunomodulatory Molecule in the Lung Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Bartlett, L. Dumoutier, J.-C. Renauld, S. V. Kotenko, C. E. McVey, H.-J. Lee, and G. L. Smith A new member of the interleukin 10-related cytokine family encoded by a poxvirus J. Gen. Virol., June 1, 2004; 85(6): 1401 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asadullah, W. Sterry, and H. D. Volk Interleukin-10 Therapy--Review of a New Approach Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Liao, W.-G. Liang, F.-W. Chen, J.-H. Hsu, J.-J. Yang, and M.-S. Chang IL-19 Induces Production of IL-6 and TNF-{alpha} and Results in Cell Apoptosis Through TNF-{alpha} J. Immunol., October 15, 2002; 169(8): 4288 - 4297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lejeune, L. Dumoutier, S. Constantinescu, W. Kruijer, J. J. Schuringa, and J.-C. Renauld Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line. PATHWAYS THAT ARE SHARED WITH AND DISTINCT FROM IL-10 J. Biol. Chem., September 6, 2002; 277(37): 33676 - 33682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vandenbroeck, I. Alloza, D. Brehmer, A. Billiau, P. Proost, N. McFerran, S. Rudiger, and B. Walker The Conserved Helix C Region in the Superfamily of Interferon-gamma /Interleukin-10-related Cytokines Corresponds to a High-affinity Binding Site for the HSP70 Chaperone DnaK J. Biol. Chem., July 5, 2002; 277(28): 25668 - 25676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wolk, S. Kunz, K. Asadullah, and R. Sabat Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? J. Immunol., June 1, 2002; 168(11): 5397 - 5402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2 J. Biol. Chem., February 22, 2002; 277(9): 7341 - 7347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dumoutier, C. Leemans, D. Lejeune, S. V. Kotenko, and J.-C. Renauld Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types J. Immunol., October 1, 2001; 167(7): 3545 - 3549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-C Renauld New insights into the role of cytokines in asthma J. Clin. Pathol., August 1, 2001; 54(8): 577 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, S. R. Presnell, J. Parrish-Novak, W. Kindsvogel, S. Jaspers, Z. Chen, S. R. Dillon, Z. Gao, T. Gilbert, K. Madden, et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist PNAS, July 24, 2001; (2001) 171303198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dumoutier, D. Lejeune, D. Colau, and J.-C. Renauld Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22 J. Immunol., June 15, 2001; 166(12): 7090 - 7095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Kotenko, L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity J. Immunol., June 15, 2001; 166(12): 7096 - 7103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-B. Demoulin, J. Van Snick, and J.-C. Renauld Interleukin-9 (IL-9) Induces Cell Growth Arrest Associated with Sustained Signal Transducer and Activator of Transcription Activation in Lymphoma Cells Overexpressing the IL-9 Receptor Cell Growth Differ., March 1, 2001; 12(3): 169 - 174. [Abstract] [Full Text]
|
|
|
|
|
|
M.-H. Xie, S. Aggarwal, W.-H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2-4 and IL-22R J. Biol. Chem., September 29, 2000; 275(40): 31335 - 31339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Kotenko, L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka Identification of the Functional Interleukin-22 (IL-22) Receptor Complex. THE IL-10R2 CHAIN (IL-10Rbeta ) IS A COMMON CHAIN OF BOTH THE IL-10 AND IL-22 (IL-10-RELATED T CELL-DERIVED INDUCIBLE FACTOR, IL-TIF) RECEPTOR COMPLEXES J. Biol. Chem., January 19, 2001; 276(4): 2725 - 2732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dumoutier, E. Van Roost, D. Colau, and J.-C. Renauld Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor PNAS, August 29, 2000; 97(18): 10144 - 10149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, S. R. Presnell, J. Parrish-Novak, W. Kindsvogel, S. Jaspers, Z. Chen, S. R. Dillon, Z. Gao, T. Gilbert, K. Madden, et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist PNAS, August 14, 2001; 98(17): 9511 - 9516. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
